Authorised AIF ICAV
Name:
Royalty Pharma Investments 2019 ICAV
Reference No:
C400096
Date of Authorisation
07 Feb 2020
Status:
ICAV
Notes:
- This fund was authorised by the Central Bank of Ireland as a closed-ended investment fund.
- This fund may be marketed to Qualifying Investors only in accordance with the Central Bank of Ireland’s AIF Rulebook/NU Notices and therefore a minimum subscription of Euro 100,000 is required.
AIFM:
Reference Number
Name
C87225
RP Management, LLC
Management Company:
Reference Number
Name
Depositary:
Reference Number
Name
C20909
State Street Custodial Services (Ireland) Limited
Page last updated on:
12 Mar 2024